The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_177438.2(DICER1):c.3428T>C (p.Leu1143Pro)

CA349475

220594 (ClinVar)

Gene: DICER1
Condition: dicer1 syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 6cde00c2-e953-4b0e-8669-393eef83e7fd
Approved on: 2022-05-18
Published on: 2022-07-08

HGVS expressions

NM_177438.2:c.3428T>C
NM_177438.2(DICER1):c.3428T>C (p.Leu1143Pro)
NC_000014.9:g.95103968A>G
CM000676.2:g.95103968A>G
NC_000014.8:g.95570305A>G
CM000676.1:g.95570305A>G
NC_000014.7:g.94640058A>G
NG_016311.1:g.58455T>C
ENST00000343455.8:c.3428T>C
ENST00000393063.6:c.3428T>C
ENST00000526495.6:c.3428T>C
ENST00000532939.3:c.3428T>C
ENST00000556045.6:c.3428T>C
ENST00000675540.1:n.1173T>C
ENST00000675995.1:c.*1744T>C
ENST00000343455.7:c.3428T>C
ENST00000393063.5:c.3428T>C
ENST00000526495.5:c.3428T>C
ENST00000527414.5:c.3428T>C
ENST00000541352.5:c.3428T>C
ENST00000554367.1:n.637T>C
ENST00000556045.5:c.122T>C
NM_001195573.1:c.3428T>C
NM_001271282.2:c.3428T>C
NM_001291628.1:c.3428T>C
NM_030621.4:c.3428T>C
NM_001271282.3:c.3428T>C
NM_001291628.2:c.3428T>C
NM_177438.3:c.3428T>C
NM_001395677.1:c.3428T>C
NM_001395678.1:c.3428T>C
NM_001395679.1:c.3428T>C
NM_001395680.1:c.3428T>C
NM_001395682.1:c.3428T>C
NM_001395683.1:c.3428T>C
NM_001395684.1:c.3428T>C
NM_001395685.1:c.3428T>C
NM_001395686.1:c.3146T>C
NM_001395687.1:c.3023T>C
NM_001395688.1:c.3023T>C
NM_001395689.1:c.3023T>C
NM_001395690.1:c.3023T>C
NM_001395691.1:c.2861T>C
NM_001395692.1:c.3428T>C
NM_001395693.1:c.3428T>C
NM_001395694.1:c.3428T>C
NM_001395695.1:c.3428T>C
NM_001395696.1:c.3023T>C
NM_001395697.1:c.1745T>C
NR_172715.1:n.3846T>C
NR_172716.1:n.4030T>C
NR_172717.1:n.3940T>C
NR_172718.1:n.3863T>C
NR_172719.1:n.3696T>C
NR_172720.1:n.3773T>C
NM_177438.3(DICER1):c.3428T>C (p.Leu1143Pro)

Benign

Met criteria codes 3
BS1 BS2 BP4
Not Met criteria codes 15
BS4 BS3 BP2 PS2 PS4 PS3 PS1 BA1 PP4 PP1 PP3 PM6 PM2 PM1 PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen DICER1 and miRNA-Processing Gene Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DICER1 Version 1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
DICER1 and miRNA-Processing Gene VCEP
The NM_177438.2:c.3428T>C variant in DICER1 is a missense variant predicted to cause substitution of leucine by proline at amino acid 1143 (p.Leu1143Pro). This variant has been seen in 40 or more unrelated females without tumors through age 50 in at least one testing laboratory (BS2; GTRs: 500031, 61756). The highest population minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.0029 (69/23442 alleles; FAF=0.0020) in African/African-American population, which is higher than the ClinGen DICER1 VCEP threshold (>0.0003) for BS1, and therefore meets this criterion (BS1). The computational predictor REVEL gives a score of 0.102, which is below the threshold of 0.5, and the splice site predictors MaxEntScan and SpliceAI indicate that the variant has no impact on splicing, evidence that does not predict a damaging effect on DICER1 function (BP4). In summary, this variant meets the criteria to be classified as BENIGN for DICER1 syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: BS2, BS1, BP4. (Bayesian Points: -9; VCEP specifications version 1; 02/11/2022)
Met criteria codes
BS1
99/41130 African/AA = 0.0024 gnomAD 3.1 (non-cancer); 69/23442 African/AA= 0.0029 gnomAD 2.1.1 (non-cancer); no homozygotes
BS2
This variant has been seen in 40 or more unrelated females without tumors through age 50 in at least one testing laboratory (BS2; Invitae SCV000261260.8, Ambry SCV000661830.3)
BP4
Score = 0.102, REVEL score <0.5; no splicing impact predicted
Not Met criteria codes
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No studies found.
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
Ambry – Seen 199x; Invitae – Seen approx. 250x w/o outstanding DICER1 phenotypes GeneDx – retinoblastoma <2yr and father w/ testicular (50s); detected on large cancer panel (0 pts)
PS3
No studies found.
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
Grantham 98; p.L1143I (ID: 857537; VUS, Invitae, G: 5); Not VCEP Curated
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.